|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01244 3D MEDICINES
Nominal 
1.970 -0.050 (-2.475%) | 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Turnover | 206,422 | -41.449% | 634,949 | 567,392 | 60,260 | 0 |
| Cost of Sales | (17,473) | -35.999% | (49,091) | (42,215) | (4,277) | -- |
| Gross Profit | 188,949 | -41.907% | 585,858 | 525,177 | 55,983 | -- |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (4,771) | 1622.383% | 837 | (658,330) | (954,872) | (319,232) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | (114,074) | -40.025% | (562,466) | (1,052,030) | (1,461,825) | (635,380) | |
| Taxation | 0 | -- | (55) | 0 | 0 | 0 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 10,565 | -9.847% | 37,824 | 27,680 | 27,733 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (103,509) | -42.007% | (524,697) | (1,024,350) | (1,434,092) | (635,380) | |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Finance Costs / (Income) | (1,082) | -- | 1,241 | (4,097) | (3,974) | 6,448 |
| Depreciation & Amortisation | -- | -- | 25,461 | 21,600 | 12,591 | 3,371 |
| Directors' Emoluments | -- | -- | 288,558 | 104,379 | 79,673 | 1,300 |
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| EPS (cts) | -42.000 | -46.835% | -230.000 | -2,252.000 | -3,672.000 | -- |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | -- | -- |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | (0.632) | (6.129) | (9.656) | -- |
| NBV per share ($) | 3.284 | -- | 3.628 | 3.689 | -- | -- |
| Remarks: | Real time quote last updated: 22/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -103,509,000 |
| %Change | -42.007% |
| EPS / (LPS) | RMB -0.420 |
| NBV Per Share (¥) | RMB 3.284 |